Impairments | Dividend reinstatement | Bonkers Bargain
News covered here include disappointing results from another company following a buy and build strategy, although the shares still rose. Elsewhere, there was an encouraging update from one of our Bonkers Bargains, with a reinstatement of the dividend , as well as promising updates from several small medical device companies with exciting technology. Read on here for this and other news.
Restore: a lot to dislike, but the cash flow is positive Restore (AIM: RST), the provider of digital and information management and secure lifecycle services, reported its results for the six months ending 30 June 2023. Restore‘s most profitable activity of Records Management involves the storage of archive boxes. As we commented previously here, this business has a track record of excluding heaps of costs in its adjusted profit, some of which look decidedly questionable to us. The fairy tale reporting now appears to have caught up with it. Restore adopts a so-called buy and build strategy, the original architects…